Overview
Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Completed
Trial end date:
2007-08-01
2007-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic (blood sugar) control on metformin therapy.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Metformin
Sitagliptin Phosphate
Criteria
Inclusion Criteria:- Patient has type 2 diabetes mellitus
- Males
- Females who are highly unlikely to become pregnant
- Patients poorly controlled while taking one or two oral antidiabetic medications
Exclusion Criteria:
- Patient has a history of type 1 diabetes mellitus or history of ketoacidosis
- Patient required insulin therapy within the prior 8 weeks
- Patient is on or has been taking Thiazolidinediones (TZDs) such as Actos®
(pioglitazone) or Avandia® (rosiglitazone) or is on or has been taking Byetta®
(exenatide) within the prior 12 weeks of the screening visit